David W Eyre1,2, Dilrini De Silva1,2, Kevin Cole3,4, Joanna Peters3,4, Michelle J Cole5, Yonatan H Grad6,7, Walter Demczuk8, Irene Martin8, Michael R Mulvey8, Derrick W Crook1,2,4, A Sarah Walker1,2, Tim E A Peto1,2, John Paul9,3,4. 1. Nuffield Department of Medicine, University of Oxford, Oxford, UK. 2. Oxford National Institute for Health Research Health Protection Research Unit, Oxford, UK. 3. Brighton and Sussex University Hospitals NHS Trust, Brighton, UK. 4. National Infection Service, Public Health England, UK. 5. Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, London, UK. 6. Department of Immunology and Infectious Diseases, Harvard TH Chan School of Public Health, Boston, MA, USA. 7. Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA. 8. National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada. 9. National Institute for Health Research Biomedical Research Centre, Oxford, UK.
Abstract
Background: Tracking the spread of antimicrobial-resistant Neisseria gonorrhoeae is a major priority for national surveillance programmes. Objectives: We investigate whether WGS and simultaneous analysis of multiple resistance determinants can be used to predict antimicrobial susceptibilities to the level of MICs in N. gonorrhoeae. Methods: WGS was used to identify previously reported potential resistance determinants in 681 N. gonorrhoeae isolates, from England, the USA and Canada, with phenotypes for cefixime, penicillin, azithromycin, ciprofloxacin and tetracycline determined as part of national surveillance programmes. Multivariate linear regression models were used to identify genetic predictors of MIC. Model performance was assessed using leave-one-out cross-validation. Results: Overall 1785/3380 (53%) MIC values were predicted to the nearest doubling dilution and 3147 (93%) within ±1 doubling dilution and 3314 (98%) within ±2 doubling dilutions. MIC prediction performance was similar across the five antimicrobials tested. Prediction models included the majority of previously reported resistance determinants. Applying EUCAST breakpoints to MIC predictions, the overall very major error (VME; phenotypically resistant, WGS-prediction susceptible) rate was 21/1577 (1.3%, 95% CI 0.8%-2.0%) and the major error (ME; phenotypically susceptible, WGS-prediction resistant) rate was 20/1186 (1.7%, 1.0%-2.6%). VME rates met regulatory thresholds for all antimicrobials except cefixime and ME rates for all antimicrobials except tetracycline. Country of testing was a strongly significant predictor of MIC for all five antimicrobials. Conclusions: We demonstrate a WGS-based MIC prediction approach that allows reliable MIC prediction for five gonorrhoea antimicrobials. Our approach should allow reasonably precise prediction of MICs for a range of bacterial species.
Background: Tracking the spread of antimicrobial-resistant Neisseria gonorrhoeae is a major priority for national surveillance programmes. Objectives: We investigate whether WGS and simultaneous analysis of multiple resistance determinants can be used to predict antimicrobial susceptibilities to the level of MICs in N. gonorrhoeae. Methods: WGS was used to identify previously reported potential resistance determinants in 681 N. gonorrhoeae isolates, from England, the USA and Canada, with phenotypes for cefixime, penicillin, azithromycin, ciprofloxacin and tetracycline determined as part of national surveillance programmes. Multivariate linear regression models were used to identify genetic predictors of MIC. Model performance was assessed using leave-one-out cross-validation. Results: Overall 1785/3380 (53%) MIC values were predicted to the nearest doubling dilution and 3147 (93%) within ±1 doubling dilution and 3314 (98%) within ±2 doubling dilutions. MIC prediction performance was similar across the five antimicrobials tested. Prediction models included the majority of previously reported resistance determinants. Applying EUCAST breakpoints to MIC predictions, the overall very major error (VME; phenotypically resistant, WGS-prediction susceptible) rate was 21/1577 (1.3%, 95% CI 0.8%-2.0%) and the major error (ME; phenotypically susceptible, WGS-prediction resistant) rate was 20/1186 (1.7%, 1.0%-2.6%). VME rates met regulatory thresholds for all antimicrobials except cefixime and ME rates for all antimicrobials except tetracycline. Country of testing was a strongly significant predictor of MIC for all five antimicrobials. Conclusions: We demonstrate a WGS-based MIC prediction approach that allows reliable MIC prediction for five gonorrhoea antimicrobials. Our approach should allow reasonably precise prediction of MICs for a range of bacterial species.
Authors: Walter Demczuk; Irene Martin; Shelley Peterson; Amrita Bharat; Gary Van Domselaar; Morag Graham; Brigitte Lefebvre; Vanessa Allen; Linda Hoang; Greg Tyrrell; Greg Horsman; John Wylie; David Haldane; Chris Archibald; Tom Wong; Magnus Unemo; Michael R Mulvey Journal: J Clin Microbiol Date: 2016-03-02 Impact factor: 5.948
Authors: Timothy M Walker; Thomas A Kohl; Shaheed V Omar; Jessica Hedge; Carlos Del Ojo Elias; Phelim Bradley; Zamin Iqbal; Silke Feuerriegel; Katherine E Niehaus; Daniel J Wilson; David A Clifton; Georgia Kapatai; Camilla L C Ip; Rory Bowden; Francis A Drobniewski; Caroline Allix-Béguec; Cyril Gaudin; Julian Parkhill; Roland Diel; Philip Supply; Derrick W Crook; E Grace Smith; A Sarah Walker; Nazir Ismail; Stefan Niemann; Tim E A Peto Journal: Lancet Infect Dis Date: 2015-06-23 Impact factor: 25.071
Authors: Yuan Li; Benjamin J Metcalf; Sopio Chochua; Zhongya Li; Robert E Gertz; Hollis Walker; Paulina A Hawkins; Theresa Tran; Cynthia G Whitney; Lesley McGee; Bernard W Beall Journal: mBio Date: 2016-06-14 Impact factor: 7.867
Authors: Walter Demczuk; Irene Martin; Pam Sawatzky; Vanessa Allen; Brigitte Lefebvre; Linda Hoang; Prenilla Naidu; Jessica Minion; Paul VanCaeseele; David Haldane; David W Eyre; Michael R Mulvey Journal: Antimicrob Agents Chemother Date: 2020-02-21 Impact factor: 5.191
Authors: Marcus Nguyen; S Wesley Long; Patrick F McDermott; Randall J Olsen; Robert Olson; Rick L Stevens; Gregory H Tyson; Shaohua Zhao; James J Davis Journal: J Clin Microbiol Date: 2019-01-30 Impact factor: 5.948
Authors: Arlene C Seña; Laura Bachmann; Christine Johnston; Teodora Wi; Kimberly Workowski; Edward W Hook; Jane S Hocking; George Drusano; Magnus Unemo Journal: Lancet Infect Dis Date: 2020-06-19 Impact factor: 25.071
Authors: Magnus Unemo; Monica M Lahra; Michelle Cole; Patricia Galarza; Francis Ndowa; Irene Martin; Jo-Anne R Dillon; Pilar Ramon-Pardo; Gail Bolan; Teodora Wi Journal: Sex Health Date: 2019-09 Impact factor: 2.706
Authors: Justin Hardick; Trevor A Crowell; Kara Lombardi; Akindiran Akintunde; Sunday Odeyemi; Andrew Ivo; George Eluwa; Jean Njab; Stefan D Baral; Rebecca G Nowak; Thomas C Quinn; Kent Barbian; Sarah Anzick; Sylvia Adebajo; Manhattan E Charurat; Julie Ake; Charlotte A Gaydos Journal: Int J STD AIDS Date: 2018-07-04 Impact factor: 1.359
Authors: Alex van Belkum; Carey-Ann D Burnham; John W A Rossen; Frederic Mallard; Olivier Rochas; William Michael Dunne Journal: Nat Rev Microbiol Date: 2020-02-13 Impact factor: 60.633